hVIVO PLC (HVO)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

17.75p

Buy

18.25p

arrow-down-0.125p (-0.69%)

Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.
Prices updated at 16 May 2025, 16:43 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Most recent dividend payment

0.002
Cash Dividend
15 May 2025
10 Apr 2025
16 May 2025
11 Jun 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202500.250.50.7511.25

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.0020-
20240.0020-
20230.0045-
2022--
2021--
2020--
2019--
2018--
2017--
2016--

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
20251.05-1.05
20240.98-0.98
2023---
2022---
2021---
2020---
2019---
2018---
2017---
2016---

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202500.0010.0020.0030.0040.005

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)20212022202320242025051015

Dividend per share data table

YearDividend per share
20250.0020
20240.0020
20230.0045
2022-
2021-
2020-
2019-
2018-
2017-
2016-

% of earnings paid to shareholders data table

YearPayout ratio (%)
202512.90
20247.91
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
Latest Financial Report as of 16 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.